StockDriftsStockDriftsTop 26 Corbin Capital Partners, L.p. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| EDR | ENDEAVOR GROUP HLDGS INC | 46.92% | 918.5K | $28.7M | -27.59%(-350.00K) | — | 2024-12-31 | |
| HYG | ISHARES TR | 16.64% | 129.6K | $10.2M | +0.00%(+0) | — | 2024-12-31 | |
| BKLN | INVESCO EXCH TRADED FD TR II | 16.6% | 482.5K | $10.2M | +0.00%(+0) | — | 2024-12-31 | |
| CORZ | CORE SCIENTIFIC INC NEW | 9.22% | 402.0K | $5.6M | -60.87%(-625.32K) | — | 2024-12-31 | |
| ABUS | ARBUTUS BIOPHARMA CORP | 3.64% | 682.5K | $2.2M | -20.02%(-170.82K) | — | 2024-12-31 | |
| EVLV | EVOLV TECHNOLOGIES HLDNGS IN | 2.28% | 353.0K | $1.4M | -42.32%(-259.00K) | — | 2024-12-31 | |
| NVTS | NAVITAS SEMICONDUCTOR CORP | 1.26% | 216.5K | $773K | new | — | 2024-12-31 | |
| ACHRWS | ARCHER AVIATION INC | 1.07% | 204.2K | $658K | +0.00%(+0) | — | 2024-12-31 | |
| ROIV | ROIVANT SCIENCES LTD | 0.9% | 46.6K | $552K | -69.09%(-104.25K) | — | 2024-12-31 | |
| DRTSW | ALPHA TAU MEDICAL LTD | 0.33% | 960.5K | $202K | +0.00%(+0) | — | 2024-12-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Corbin Capital Partners, L.p. reports $61.25M in US-listed equity holdings across 27 positions in its most recent 13F filing. Its largest disclosed positions are EDR (46.9%), HYG (16.6%) and BKLN (16.6%). Figures reflect the Q4 2024 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Corbin Capital Partners, L.p., compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Corbin Capital Partners, L.p.’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1509874). View Corbin Capital Partners, L.p.’s 13F filings on SEC